Key Finding
Taohe Chengqi Decoction significantly reduced brain infarct volume and inflammation in stroke-model rats by regulating the PI3K/AKT/HIF-1α signaling pathway and arachidonic acid metabolism through 22 bioactive blood-absorbed constituents.
Researchers investigated how a traditional Chinese herbal formula called Taohe Chengqi Decoction (THCQD) might help protect the brain after stroke. Stroke occurs when blood flow to the brain is blocked and then restored, causing inflammation and damage. This study used rats with induced strokes to test whether THCQD could reduce this injury. The researchers used advanced laboratory techniques to identify 84 different compounds in the formula, including 22 that were absorbed into the bloodstream, such as emodin, amygdalin, and resveratrol. They found that THCQD significantly reduced brain swelling, decreased the size of damaged brain tissue, and improved neurological function in the rats. The herbal formula worked through multiple mechanisms: it reduced inflammation by regulating specific cellular pathways (including PI3K/AKT and HIF-1 alpha), improved metabolism of important substances like arachidonic acid, and helped preserve brain cell survival. The study showed that THCQD's effectiveness comes from its multiple active ingredients working together on different targets in the body, rather than a single compound acting alone. While this research was conducted in animals and focused on herbal medicine rather than acupuncture specifically, it demonstrates how traditional Chinese medicine approaches may offer multi-faceted therapeutic benefits for stroke recovery through their complex formulations. If you're considering traditional Chinese medicine for stroke recovery or prevention, it's important to work with a qualified and licensed practitioner who can provide appropriate guidance.
This study investigated Taohe Chengqi Decoction's mechanisms in cerebral ischemia-reperfusion injury using a rat MCAO/R model combined with LC-MS, network pharmacology, metabolomics, and molecular docking. Researchers identified 84 compounds, including 22 blood-absorbed constituents (emodin, amygdalin, resveratrol). THCQD significantly reduced infarct volume, improved neurological function scores, and preserved tissue morphology. Network pharmacology predicted HIF-1 and PI3K/AKT pathway modulation, confirmed via Western blotting. Metabolomics revealed normalization of arachidonic acid and glutathione metabolism disturbances. Molecular docking validated component interactions with the PTGS2/ALOX15-NF-κB/PI3K/AKT-HIF-1α/VEGFA signaling axis. Clinical takeaway: THCQD demonstrates neuroprotective effects through multi-target mechanisms involving inflammatory suppression and metabolic restoration, supporting its traditional use in stroke management. The multi-component synergy suggests advantages of whole-formula approaches over single-compound interventions in treating complex cerebrovascular conditions.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Gastrodin and gastrodigenin from Gastrodia elata Blume promote neurogenesis and show therapeutic potential for multiple neurological conditions including Alzheimer's disease, depression, stroke, and amnesia.
📌 Amygdalin significantly improved neurological function and reduced brain inflammation after ischemic stroke by specifically targeting the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
📌 Buzhong Yiqi Tang significantly reduced autoimmune thyroid inflammation and antibody levels by down-regulating the Toll-like receptor pathway and associated inflammatory genes (TLR8, JUN, TICAM2, TIRAP, IL-1β).